... Bosutinib (Bosulif) — This drug is used to treat Philadelphia chromosome-positive CML in the chronic phase. Dasatinib (Phyrago, Sprycel) and nilotinib (Tasigna) and — These drugs are FDA-approved to treat some cases of CML, particularly for individuals who become resistant to first-line therapy. ...
7 Treatment Options for Myeloproliferative Neoplasms
... Bosutinib (Bosulif) — This drug is used to treat Philadelphia chromosome-positive CML in the chronic phase. Dasatinib (Phyrago, Sprycel) and nilotinib (Tasigna) and — These drugs are FDA-approved to treat some cases of CML, particularly for individuals who become resistant to first-line therapy. ...